| abstract |
The present invention is for the production of a medicament used for the treatment of neuropathic pain, particularly neuropathic allodynia, particularly chronic neuropathic allodynia, and more generally reduces pain. It relates to the use of β-adrenergic receptor agonists as active ingredients for the production of medicaments. The main field to which the present invention applies is in the biomedical field, more specifically in the field of therapeutics. The present invention specifically aims to provide a drug that can be used as an alternative to the antidepressants currently used to treat pain. The present invention is used in the human and veterinary clinical field. |